These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35222998)

  • 1. Intravenous Drug Use: a Significant Risk Factor for Serratia Bacteremia.
    McCann T; Elabd H; Blatt SP; Brandt DM
    Ther Adv Infect Dis; 2022; 9():20499361221078116. PubMed ID: 35222998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serratia bacteremia in a large university hospital: trends in antibiotic resistance during 10 years and implications for antibiotic use.
    Choi SH; Kim YS; Chung JW; Kim TH; Choo EJ; Kim MN; Kim BN; Kim NJ; Woo JH; Ryu J
    Infect Control Hosp Epidemiol; 2002 Dec; 23(12):740-7. PubMed ID: 12517017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morbidity and mortality of Serratia marcescens bacteraemia during the substance use epidemic.
    Bloom R; Thakarar K; Rokas KE
    Int J Antimicrob Agents; 2023 Oct; 62(4):106934. PubMed ID: 37500021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods.
    Su PA; Wu LT; Cheng KC; Ko WC; Chuang YC; Yu WL
    J Microbiol Immunol Infect; 2010 Feb; 43(1):26-34. PubMed ID: 20434120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nosocomial infection in the community hospital: severe infection due to Serratia species.
    Haddy RI; Mann BL; Nadkarni DD; Cruz RF; Elshoff DJ; Buendia FC; Domers TA; Oberheu AM
    J Fam Pract; 1996 Mar; 42(3):273-7. PubMed ID: 8636679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children.
    Zaoutis TE; Goyal M; Chu JH; Coffin SE; Bell LM; Nachamkin I; McGowan KL; Bilker WB; Lautenbach E
    Pediatrics; 2005 Apr; 115(4):942-9. PubMed ID: 15805368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Chopra T; Marchaim D; Veltman J; Johnson P; Zhao JJ; Tansek R; Hatahet D; Chaudhry K; Pogue JM; Rahbar H; Chen TY; Truong T; Rodriguez V; Ellsworth J; Bernabela L; Bhargava A; Yousuf A; Alangaden G; Kaye KS
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3936-42. PubMed ID: 22547616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Third-Generation Cephalosporin Resistance and Associated Discordant Antibiotic Treatment in Emergency Department Febrile Urinary Tract Infections.
    Mark DG; Hung YY; Salim Z; Tarlton NJ; Torres E; Frazee BW
    Ann Emerg Med; 2021 Sep; 78(3):357-369. PubMed ID: 33781606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experiences of the infections caused by extended-spectrum beta-lactamase-producing Serratia marcescens at a medical center in Taiwan.
    Cheng KC; Chuang YC; Wu LT; Huang GC; Yu WL
    Jpn J Infect Dis; 2006 Jun; 59(3):147-52. PubMed ID: 16785693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales ("MERINO-3"): study protocol for a multicentre, open-label randomised non-inferiority trial.
    Stewart AG; Harris PNA; Chatfield MD; Littleford R; Paterson DL
    Trials; 2021 Apr; 22(1):301. PubMed ID: 33888139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for mortality in patients with Serratia marcescens bacteremia.
    Kim SB; Jeon YD; Kim JH; Kim JK; Ann HW; Choi H; Kim MH; Song JE; Ahn JY; Jeong SJ; Ku NS; Han SH; Choi JY; Song YG; Kim JM
    Yonsei Med J; 2015 Mar; 56(2):348-54. PubMed ID: 25683980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the antibiotic resistance rates of
    Simsek M
    Niger J Clin Pract; 2019 Jan; 22(1):125-130. PubMed ID: 30666031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for and Outcomes of Bacteremia Caused by Extended-Spectrum ß-Lactamase-Producing Escherichia coli and Klebsiella Species at a Canadian Tertiary Care Hospital.
    Nguyen ML; Toye B; Kanji S; Zvonar R
    Can J Hosp Pharm; 2015; 68(2):136-43. PubMed ID: 25964685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-intravenous carbapenem-sparing antibiotics for definitive treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamase (ESBL) or AmpC β-lactamase: A propensity score study.
    Meije Y; Pigrau C; Fernández-Hidalgo N; Clemente M; Ortega L; Sanz X; Loureiro-Amigo J; Sierra M; Ayestarán A; Morales-Cartagena A; Ribera A; Duarte A; Abelenda G; Rodríguez-Baño J; Martínez-Montauti J
    Int J Antimicrob Agents; 2019 Aug; 54(2):189-196. PubMed ID: 31075401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serratia marcescens Endocarditis in Prosthetic Valves.
    Jamil A; Sharma H; Ali R; Klukowicz A; Taha A; Paige A; Bellary S; Ahmed A; Miller R; Chow P
    Cureus; 2023 Nov; 15(11):e48957. PubMed ID: 38106730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marvelous but Morbid: Infective endocarditis due to
    Phadke VK; Jacob JT
    Infect Dis Clin Pract (Baltim Md); 2016 May; 24(3):143-150. PubMed ID: 27346925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae blood isolates with inducible AmpC β-lactamase.
    Cheong HS; Ko KS; Kang CI; Chung DR; Peck KR; Song JH
    Microb Drug Resist; 2012 Aug; 18(4):446-52. PubMed ID: 22409779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outbreak of extended-spectrum beta-lactamase producing Serratia marcescens in an intensive care unit.
    Pagani L; Luzzaro F; Ronza P; Rossi A; Micheletti P; Porta F; Romero E
    FEMS Immunol Med Microbiol; 1994 Nov; 10(1):39-46. PubMed ID: 7874077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia.
    Tamma PD; Han JH; Rock C; Harris AD; Lautenbach E; Hsu AJ; Avdic E; Cosgrove SE;
    Clin Infect Dis; 2015 May; 60(9):1319-25. PubMed ID: 25586681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefepime shows good efficacy and no antibiotic resistance in pneumonia caused by Serratia marcescens and Proteus mirabilis - an observational study.
    Yayan J; Ghebremedhin B; Rasche K
    BMC Pharmacol Toxicol; 2016 Mar; 17():10. PubMed ID: 27004519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.